189 Antitumor Effect of the MTor Inhibitor Everolimus in Combination with Trastuzumab On Human Breast Cancer Stem Cells in Vitro and in Vivo

2012 ◽  
Vol 48 ◽  
pp. S95
Author(s):  
J. Zhang ◽  
X. Zhang ◽  
S. Zhang ◽  
Y. Liu ◽  
Y. Ma ◽  
...  
Tumor Biology ◽  
2012 ◽  
Vol 33 (5) ◽  
pp. 1349-1362 ◽  
Author(s):  
Yuanxi Zhu ◽  
Xiaobei Zhang ◽  
Yan Liu ◽  
Sheng Zhang ◽  
Jingjing Liu ◽  
...  

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e11514-e11514 ◽  
Author(s):  
J. Zhang ◽  
X. b. Zhang ◽  
Y. Liu ◽  
J. j. Liu ◽  
Y. Ma ◽  
...  

Stem Cells ◽  
2012 ◽  
Vol 30 (10) ◽  
pp. 2065-2075 ◽  
Author(s):  
Caihua Zhu ◽  
Ka-Wing Cheng ◽  
Nengtai Ouyang ◽  
Liqun Huang ◽  
Yu Sun ◽  
...  

2007 ◽  
Vol 6 (9) ◽  
pp. 1476-1485 ◽  
Author(s):  
Yaochen Li ◽  
Linghong Kong ◽  
Ye Yang ◽  
Kangsheng Li

PLoS ONE ◽  
2021 ◽  
Vol 16 (2) ◽  
pp. e0247694
Author(s):  
Septelia Inawati Wanandi ◽  
Agus Limanto ◽  
Elvira Yunita ◽  
Resda Akhra Syahrani ◽  
Melva Louisa ◽  
...  

2010 ◽  
Vol 120 (2) ◽  
pp. 485-497 ◽  
Author(s):  
Christophe Ginestier ◽  
Suling Liu ◽  
Mark E. Diebel ◽  
Hasan Korkaya ◽  
Ming Luo ◽  
...  

2021 ◽  
Vol 13 (4) ◽  
pp. 355-63
Author(s):  
Yalista Fatia Nadia ◽  
Resda Akhra Syahrani ◽  
Sekar Arumsari ◽  
Mohamad Sadikin ◽  
Septelia Inawati Wanandi

BACKGROUND: Cancer stem cells (CSCs) is defined as tumor initiating cells within tumor that maintain stemness properties and tumorigenicity. Extracellular pH of CSCs in in vitro condition is important for supporting cell proliferation which may also regulate the expression of stemness markers such as OCT4. This work aimed to examine the effect of cell culture media on the proliferation and stemness of human breast cancer stem cells (BCSCs).METHODS: Human CD24-/CD44+ BCSCs were grown in Dulbecco's Modified Eagle Medium/F-12 (DMEM/F-12) with 15mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), without HEPES and adjusted to pH 7.4, or without HEPES but pH was not adjusted. BCSCs were grown under standard conditions for various days. Viable cell number was measured using trypan blue exclusion, whereas proliferation rate using MTS assay. OCT4 mRNA and protein were analyzed using quantitative real time PCR (qRT-PCR) and Western Blot assay, respectively. In vitro tumorigenic activity was determined using mammosphere formation unit (MFU) assay.RESULTS: Our results showed a higher viable cell number and proliferation of BCSCs in DMEM/F-12 HEPES (-) compared to HEPES (+) medium until 4 day incubation. OCT4 mRNA and protein level, as well as MFU of BCSCs were significantly higher in HEPES (-) compared to HEPES (+) medium on day 2.CONCLUSION: DMEM/F-12 medium without HEPES facilitates CD24-/CD44+ BCSCs to have higher proliferation and stemness on day 2 incubation compared to those with HEPES.KEYWORDS: breast cancer, cancer stem cell, OCT4, stemness, proliferation


Sign in / Sign up

Export Citation Format

Share Document